Mammoth Research

Mammoth Private Capital invests in early to growth stage life science and bio tech companies. We seek to add value through a deep functional understanding of healthcare delivery, contracting, private and CMS reimbursement, creation of new CMS reimbursement pathways, FDA, EU and data regulatory requirements and informative data technologies. Additionally, our team has strong relationships with leading physician, surgeon, healthcare executive and financial technology thought leaders in the US and around the world.

Thomas Martin

CEO

2 past transactions

MiRus

Venture Round in 2021
MiRus is a medical device company focused on designing innovative solutions for the treatment of spinal and orthopedic degeneration and deformities.

nSight Surgical

Pre Seed Round in 2021
nSight is revolutionizing surgery with the first machine learning platform to ensure hospital patient safety and streamline operative workflow. By recognizing patient safety moments in the operating room, the platform improves patient safety and increases efficiency across the entire hospital ecosystem.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.